| # | Drug | Count |
|---|---|---|
| 0 | CANDESARTAN | 6 |
| 1 | INSULIN GLARGINE | 6 |
| 2 | LANSOPRAZOLE | 6 |
| 3 | QUININE | 6 |
| 4 | QUININE SULFATE | 6 |
| 5 | ACYCLOVIR | 2 |
| 6 | CERTOLIZUMAB PEGOL | 2 |
| 7 | COPPER | 2 |
| 8 | DIAZEPAM | 2 |
| 9 | DIAZEPAM ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | QUININE | 6 | 0.0007 |
| 1 | CANDESARTAN | 6 | 0.0002 |
| 2 | VALSARTAN AND HYDROCHLOROTHIAZIDE | 1 | 0.0001 |
| 3 | COPPER | 2 | 0.0000 |
| 4 | ESTRADIOL TRANSDERMAL | 2 | 0.0000 |
| 5 | LANSOPRAZOLE | 6 | 0.0000 |
| 6 | BELIMUMAB | 1 | 0.0000 |
| 7 | INSULIN GLARGINE | 6 | 0.0000 |
| 8 | ESTRADIOL | 2 | 0.0000 |
| 9 | DIAZEPAM ORAL | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-17A Antagonist [EPC] | 2 | 0.0001 |
| 1 | Copper-containing Intrauterine Device [EPC] | 2 | 0.0000 |
| 2 | B Lymphocyte Stimulator-specific Inhibitor [EPC] | 1 | 0.0000 |
| 3 | Integrin Receptor Antagonist [EPC] | 2 | 0.0000 |
| 4 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 5 | Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0000 |
| 6 | Insulin Analog [EPC] | 6 | 0.0000 |
| 7 | Estrogen [EPC] | 2 | 0.0000 |
| 8 | Proton Pump Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Serotonin-3 Receptor Antagonist [EPC] | 1 | 0.0000 |